TTrialPathMatch Me to Trials
← Back to trials
RecruitingAlzheimer Disease

Study on the Health Economic Burden of Alzheimer's Disease in China

Eligible age

40–100 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.

Sponsor: Xuanwu Hospital, Beijing

Source: ClinicalTrials.gov · NCT05995418 · last updated 2026-06-05

Study on the Health Economic Burden of Alzheimer's Disease in China · TrialPath